vs
Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and ENTEGRIS INC (ENTG). Click either name above to swap in a different company.
Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $823.9M, roughly 1.5× ENTEGRIS INC). ENTEGRIS INC runs the higher net margin — 6.0% vs 0.9%, a 5.1% gap on every dollar of revenue. On growth, ENTEGRIS INC posted the faster year-over-year revenue change (-3.1% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 3.4%).
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
Entegris, Inc. is a supplier of materials for the semiconductor and other high-tech industries. Entegris has approximately 8,000 employees throughout its global operations. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. The company’s corporate headquarters are in Billerica, Massachusetts.
ALHC vs ENTG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $823.9M |
| Net Profit | $11.4M | $49.4M |
| Gross Margin | — | 43.8% |
| Operating Margin | — | 12.7% |
| Net Margin | 0.9% | 6.0% |
| Revenue YoY | -74.7% | -3.1% |
| Net Profit YoY | — | -51.7% |
| EPS (diluted) | — | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.0B | $823.9M | ||
| Q3 25 | $993.7M | $807.1M | ||
| Q2 25 | $1.0B | $792.4M | ||
| Q1 25 | $926.9M | $773.2M | ||
| Q4 24 | $701.2M | $849.8M | ||
| Q3 24 | $692.4M | $807.7M | ||
| Q2 24 | $681.3M | $812.7M |
| Q1 26 | $11.4M | — | ||
| Q4 25 | $-11.0M | $49.4M | ||
| Q3 25 | $3.7M | $70.5M | ||
| Q2 25 | $15.7M | $52.8M | ||
| Q1 25 | $-9.1M | $62.9M | ||
| Q4 24 | $-31.1M | $102.2M | ||
| Q3 24 | $-26.4M | $77.6M | ||
| Q2 24 | $-24.0M | $67.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 43.5% | ||
| Q2 25 | — | 44.4% | ||
| Q1 25 | — | 46.1% | ||
| Q4 24 | — | 45.6% | ||
| Q3 24 | — | 46.0% | ||
| Q2 24 | — | 46.2% |
| Q1 26 | — | — | ||
| Q4 25 | -1.0% | 12.7% | ||
| Q3 25 | 0.8% | 15.2% | ||
| Q2 25 | 2.2% | 13.4% | ||
| Q1 25 | -0.6% | 15.8% | ||
| Q4 24 | -3.2% | 17.6% | ||
| Q3 24 | -2.8% | 16.9% | ||
| Q2 24 | -2.7% | 16.0% |
| Q1 26 | 0.9% | — | ||
| Q4 25 | -1.1% | 6.0% | ||
| Q3 25 | 0.4% | 8.7% | ||
| Q2 25 | 1.5% | 6.7% | ||
| Q1 25 | -1.0% | 8.1% | ||
| Q4 24 | -4.4% | 12.0% | ||
| Q3 24 | -3.8% | 9.6% | ||
| Q2 24 | -3.5% | 8.3% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.04 | $0.33 | ||
| Q3 25 | $0.02 | $0.46 | ||
| Q2 25 | $0.07 | $0.35 | ||
| Q1 25 | $-0.05 | $0.41 | ||
| Q4 24 | $-0.15 | $0.67 | ||
| Q3 24 | $-0.14 | $0.51 | ||
| Q2 24 | $-0.13 | $0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $705.6M | $360.4M |
| Total DebtLower is stronger | — | $3.7B |
| Stockholders' EquityBook value | $206.9M | $4.0B |
| Total Assets | $1.3B | $8.4B |
| Debt / EquityLower = less leverage | — | 0.94× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $705.6M | — | ||
| Q4 25 | $604.2M | $360.4M | ||
| Q3 25 | $644.1M | $399.8M | ||
| Q2 25 | $503.8M | $376.8M | ||
| Q1 25 | $479.5M | $340.9M | ||
| Q4 24 | $470.6M | $329.2M | ||
| Q3 24 | $381.0M | $432.1M | ||
| Q2 24 | $363.7M | $320.0M |
| Q1 26 | — | — | ||
| Q4 25 | $323.2M | $3.7B | ||
| Q3 25 | $322.7M | $3.8B | ||
| Q2 25 | $322.3M | $4.0B | ||
| Q1 25 | $321.9M | $4.0B | ||
| Q4 24 | $321.4M | $4.0B | ||
| Q3 24 | $212.0M | $4.1B | ||
| Q2 24 | $211.7M | $4.1B |
| Q1 26 | $206.9M | — | ||
| Q4 25 | $179.3M | $4.0B | ||
| Q3 25 | $161.9M | $3.9B | ||
| Q2 25 | $141.0M | $3.8B | ||
| Q1 25 | $108.1M | $3.7B | ||
| Q4 24 | $99.9M | $3.7B | ||
| Q3 24 | $114.5M | $3.6B | ||
| Q2 24 | $123.7M | $3.5B |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.1B | $8.4B | ||
| Q3 25 | $1.1B | $8.4B | ||
| Q2 25 | $1.0B | $8.4B | ||
| Q1 25 | $895.6M | $8.4B | ||
| Q4 24 | $782.1M | $8.4B | ||
| Q3 24 | $692.3M | $8.5B | ||
| Q2 24 | $716.3M | $8.3B |
| Q1 26 | — | — | ||
| Q4 25 | 1.80× | 0.94× | ||
| Q3 25 | 1.99× | 0.99× | ||
| Q2 25 | 2.29× | 1.05× | ||
| Q1 25 | 2.98× | 1.06× | ||
| Q4 24 | 3.22× | 1.08× | ||
| Q3 24 | 1.85× | 1.15× | ||
| Q2 24 | 1.71× | 1.18× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $128.7M | $192.0M |
| Free Cash FlowOCF − Capex | — | $134.0M |
| FCF MarginFCF / Revenue | — | 16.3% |
| Capex IntensityCapex / Revenue | — | 7.0% |
| Cash ConversionOCF / Net Profit | 11.27× | 3.89× |
| TTM Free Cash FlowTrailing 4 quarters | — | $396.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $128.7M | — | ||
| Q4 25 | $-50.4M | $192.0M | ||
| Q3 25 | $144.6M | $249.5M | ||
| Q2 25 | $29.1M | $113.5M | ||
| Q1 25 | $16.6M | $140.4M | ||
| Q4 24 | $-8.7M | $176.1M | ||
| Q3 24 | $26.2M | $197.2M | ||
| Q2 24 | $23.5M | $111.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-55.4M | $134.0M | ||
| Q3 25 | $139.1M | $182.8M | ||
| Q2 25 | $21.1M | $47.0M | ||
| Q1 25 | $8.4M | $32.4M | ||
| Q4 24 | $-18.0M | $68.6M | ||
| Q3 24 | $16.9M | $115.0M | ||
| Q2 24 | $11.8M | $51.9M |
| Q1 26 | — | — | ||
| Q4 25 | -5.5% | 16.3% | ||
| Q3 25 | 14.0% | 22.6% | ||
| Q2 25 | 2.1% | 5.9% | ||
| Q1 25 | 0.9% | 4.2% | ||
| Q4 24 | -2.6% | 8.1% | ||
| Q3 24 | 2.4% | 14.2% | ||
| Q2 24 | 1.7% | 6.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 7.0% | ||
| Q3 25 | 0.6% | 8.3% | ||
| Q2 25 | 0.8% | 8.4% | ||
| Q1 25 | 0.9% | 14.0% | ||
| Q4 24 | 1.3% | 12.7% | ||
| Q3 24 | 1.3% | 10.2% | ||
| Q2 24 | 1.7% | 7.3% |
| Q1 26 | 11.27× | — | ||
| Q4 25 | — | 3.89× | ||
| Q3 25 | 38.77× | 3.54× | ||
| Q2 25 | 1.86× | 2.15× | ||
| Q1 25 | — | 2.23× | ||
| Q4 24 | — | 1.72× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALHC
Segment breakdown not available.
ENTG
| Fabs | $516.3M | 63% |
| Equipment And Engineering | $121.8M | 15% |
| Chemical And Materials | $83.8M | 10% |
| Other | $61.7M | 7% |
| Non Semi | $40.3M | 5% |
